The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-12 of 12 articles
A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first-in-human study
Haude M,
Wlodarczak A,
van der Schaaf R,
Torzewski J,
Ferdinande B,
Escaned J,
Iglesias JF,
Bennett J,
Toth GG,
Joner M,
Toelg R,
Wiemer M,
Olivecrano G,
Vermeersch P,
Garcia-Garcia H,
Waksman R
August 7, 2023 | 10.4244/EIJ-D-23-00326
Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial
Kerkmeijer L,
Renkens M,
Tijssen R,
Hofma S,
van der Schaaf R,
Arkenbout EK,
Weevers A,
Garcia-Garcia H,
Kraak R,
Piek J,
Tijssen J,
Henriques J,
de Winter R,
Wykrzykowska JJ
March 18, 2022 | 10.4244/EIJ-D-21-00419
Outcomes of bioresorbable vascular scaffolds versus everolimus-eluting stents by coronary complexity: a sub-analysis of the AIDA trial
Kraak R,
Tijssen R,
van Dongen I,
Elias J,
Hofma S,
van der Schaaf R,
Arkenbout EK,
Weevers A,
Tijssen J,
Piek J,
de Winter R,
Henriques J,
Wykrzykowska JJ
December 4, 2020 | 10.4244/EIJ-D-18-00884
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in routine PCI: three-year clinical outcomes from the AIDA trial
Kerkmeijer L,
Tijssen R,
Hofma S,
van der Schaaf R,
Arkenbout KE,
Kraak R,
Weevers A,
Piek J,
de Winter R,
Tijssen J,
Henriques J,
Wykrzykowska JJ,
Ijsselmuiden A,
Kauer F,
Beijk M,
Vis MM,
Koch K
September 20, 2019 | 10.4244/EIJ-D-19-00325
Complete two-year follow-up with formal non-inferiority testing on primary outcomes of the AIDA trial comparing the Absorb bioresorbable scaffold with the XIENCE drug-eluting metallic stent in routine PCI
Tijssen R,
Kraak R,
Hofma S,
van der Schaaf R,
Arkenbout EK,
Weevers A,
Elias J,
van Dongen I,
Koch K,
Baan Jr J,
Vis MM,
de Winter R,
Piek J,
Tijssen J,
Henriques J,
Wykrzykowska JJ
July 20, 2018 | 10.4244/EIJ-D-18-00335
Three-year clinical outcome in the Primary Stenting of Totally Occluded Native Coronary Arteries III (PRISON III) trial: a randomised comparison between sirolimus-eluting stent implantation and zotarolimus-eluting stent implantation for the treatment of total coronary occlusions
Teeuwen K,
Van den Branden B,
Koolen J,
van der Schaaf R,
Henriques J,
Thijssen J,
Kelder J,
Vermeersch P,
Rensing BJ,
Suttorp MJ
March 20, 2015 | 10.4244/EIJY14M08_07
Safety and feasibility of a PAclitaxel-eluting balloon angioplasty in Primary Percutaneous coronary intervention in Amsterdam (PAPPA): one-year clinical outcome of a pilot study
Vos N,
Dirksen M,
Vink M,
van Nooijen F,
Amoroso G,
Herrman JP,
Kiemeneij F,
Patterson M,
Slagboom T,
van der Schaaf R
September 28, 2014 | 10.4244/EIJV10I5A101
Primary Stenting of Totally Occluded Native Coronary Arteries III (PRISON III): a randomised comparison of sirolimus-eluting stent implantation with zotarolimus-eluting stent implantation for the treatment of total coronary occlusions
Van den Branden B,
Teeuwen K,
Koolen J,
van der Schaaf R,
Henriques J,
Thijssen J,
Kelder J,
Vermeersch P,
Rensing BJ,
Suttorp MJ
November 29, 2013 | 10.4244/EIJV9I7A138
Latest news
NEW ISSUE
The Bifurcation ARC consensus; impact of P2Y12 de-escalation in HBR; 5-year outcomes of the TARGET trial and more...
December 4, 2023
STATE-OF-THE-ART
Free access collection all year long
December 4, 2023
AHEAD OF PRINT
Poor improvement of post-PCI iFR in LAD
FREE ARTICLE - Mitsuaki Matsumura et al
November 30, 2023
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
PCR London Valves 2023
November 16, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023